Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04921787 · ClinicalTrials.gov registry record · NA

EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy

A NA study of Substance Use Disorders and Opioid Use Disorder, Moderate, sponsored by Gavin Bart.

Active
Registry status
NA
Development phase
24
Enrollment target
4
Study locations

NCT04921787 is a NA study of Substance Use Disorders and Opioid Use Disorder, Moderate that is active but no longer recruiting, run by Gavin Bart. The registered enrollment target is 24 participants, below the 500-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (95% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04921787, a NA study of Substance Use Disorders and Opioid Use Disorder, Moderate, is active but no longer recruiting, sponsored by Gavin Bart.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
4
Study locations

Study Summary

This study is a multi-site, cluster randomized, two group implementation trial comparing a low- versus high-intensity implementation strategy for supporting hospital-based opioid use disorder treatment (HBOT) in community hospital settings where medication for opioid use disorder (MOUD) treatment has not been implemented.

Interventions

  • OTHER Low Intensity
  • OTHER High Intensity

Study Locations (4)

Massachusetts

  • Boston University - Boston

Minnesota

  • Hennepin Healthcare Research Institute - Minneapolis

New York

  • New York University - New York

Oregon

  • Oregon Health & Science University - Portland

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2021-10-22
Est. Completion 2026-02-28
Phase NA

Sponsor

Gavin Bart

2 total trials

What the Registry Record Tells You About NCT04921787

The ClinicalTrials.gov registry entry for NCT04921787 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 500-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (95% lower). The listed sponsor is Gavin Bart, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Substance Use Disorders appearing as the primary indexed condition, and to 2 interventions - of which Low Intensity is the first listed.

NCT04921787 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Massachusetts, Minnesota, New York.

Frequently Asked Questions

What is clinical trial NCT04921787 about?

NCT04921787 is a clinical study titled "EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy". This study is a multi-site, cluster randomized, two group implementation trial comparing a low- versus high-intensity implementation strategy for supporting hospital-based opioid use disorder treatment (HBOT) in community hospital settings where medication for opioid use disorder (MOUD) treatment ha...

What is the current status of trial NCT04921787?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2021-10-22. Estimated completion is 2026-02-28.

What conditions does trial NCT04921787 study?

This clinical trial studies the following conditions: Substance Use Disorders, Opioid Use Disorder, Moderate, Opioid Use Disorder, Severe.

What interventions are being tested in trial NCT04921787?

The interventions under investigation include: Low Intensity (OTHER), High Intensity (OTHER).

Who is sponsoring clinical trial NCT04921787?

This trial is sponsored by Gavin Bart, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04921787 being conducted?

This trial has 4 study locations across Massachusetts, Minnesota, New York, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.